Praxis Precision Medicines, Inc. (PRAX)
$259.86-1.40%Close
SELLCRISIS · day 19
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $7.2B
- Beta
- 2.78
- P/E (TTM)
- -21.63
- Short % float
- 13.73%
- Days to cover
- 7.2
- SI change
- +10.3%
- 1W
- -12.06%
- 1M
- -23.25%
- vs SPY 1W
- -13.22%
- vs SPY 1M
- -26.24%
Industry peers
FMP comparable companies · ranked by market cap
- KYMRSELLKymera Therapeutics, Inc.$9.0BBEARQ 25$109.85+2.84%
- CRNXBUYCrinetics Pharmaceuticals, Inc.$9.0BBULLQ 26$84.95+0.00%
- IMVTSELLImmunovant, Inc.$6.9BCRISISQ 25$33.25+0.69%
- CNTACentessa Pharmaceuticals plc$6.3B$40.50
- LGNDBUYLigand Pharmaceuticals Incorporated$6.1BRECOVERYQ 15$306.77+2.31%
- AKROAkero Therapeutics, Inc.$4.5B$54.65
- XENESELLXenon Pharmaceuticals Inc.$3.6BCRISISQ 22$37.57+0.77%
- ACADSELLAcadia Pharmaceuticals Inc.$3.4BCRISISQ 18$20.11+1.02%
- VKTXSELLViking Therapeutics, Inc.$3.4BCRISISQ 22$29.28+2.81%
- SLNOSoleno Therapeutics, Inc.$2.8B$53.01
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
ANALYST & RATINGS
LOADING…Loading analyst data…
Company news
FAQ
- What is LOPJLB’s current signal on PRAX?
- LOPJLB’s latest quantitative signal on Praxis Precision Medicines, Inc. (PRAX) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is PRAX in?
- Praxis Precision Medicines, Inc. (PRAX) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does Praxis Precision Medicines, Inc. (PRAX) do?
- Praxis Precision Medicines, Inc. is a biopharmaceutical firm operating at the clinical stage, dedicated to creating innovative treatments for central nervous system (CNS) conditions that stem from an imbalance in neuronal activity. The company's primary investigational compounds currently undergoing evaluation include: PRAX-114, an extrasynaptic-preferring positive allosteric modulator of the G…